EUVIMEDEUVIMED entdecken
Crossref

Human Type‐I Interferon Omega Holds Potent Antiviral Properties and Promotes Cytolytic CD8 + T Cell Responses

Hoang Oanh Nguyen, Patricia Recordon Pinson, Marie-Line Andreola, Laura Papagno, Victor Appay

European Journal of Immunology · 2025

DOI: 10.1002/eji.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Hoang Oanh Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Bordeaux, CNRS, Inserm, ImmunoConcEpT, UMR 5164, ERL 1303, Bordeaux, France. Hauptthemen laut MEDLINE: SARS-CoV-2, Interferon Type I, CD8-Positive T-Lymphocytes, Antiviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: University of Bordeaux, Université de Bordeaux.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The type‐I interferon family is well known for its critical role in innate immunity. It comprises several members, among which IFN‐α 2 and IFN‐β are the most extensively studied, with important antiviral and immune‐modulatory functions. Recent findings linking autoantibodies against type‐I interferons to severe COVID‐19 suggest a potential role for IFN‐ω in combating SARS‐CoV‐2 infection. However, little is known about human IFN‐ω, as most research on this interferon has been conducted in feline models. Here, we demonstrate that human IFN‐ω is secreted at levels comparable to those of IFN‐α 2 or IFN‐β upon stimulation with inflammatory agonists and triggers a robust antiviral response, inhibiting SARS‐CoV‐2 infection in vitr o . Moreover, IFN‐ω enhances the effector functions of antigen‐specific CD8 + T cells primed de novo from healthy donor cells, highlighting its capacity to promote strong cellular immunity. Our results position IFN‐ω as a key member of the type‐I interferon family, with promising potential for therapeutic and vaccine applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Interferon Type ICD8-Positive T-LymphocytesAntiviral AgentsCOVID-19HumansInterferon-alpha

Stichwörter der Autor:innen

CD8+ T cellsSARS‐CoV‐2interferon omegatype‐I interferons

Substanzen

Interferon Type IAntiviral Agentsinterferon omega 1Interferon-alpha

Autor:innen und Institutionen

  • University of Bordeaux, CNRS, Inserm, ImmunoConcEpT, UMR 5164, ERL 1303, Bordeaux, France.
  • University of Bordeaux, CNRS, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France.
  • University of Bordeaux, TBMCore UAR 3427, UB'L3 Facility, Bordeaux, France.

Förderung

  • University of Bordeaux
  • Université de Bordeaux

Zitieren

APA

Nguyen, H. O., Pinson, P. R., Andreola, M. L., Papagno, L., & Appay, V. (2025). Human Type‐I Interferon Omega Holds Potent Antiviral Properties and Promotes Cytolytic CD8 + T Cell Responses. European Journal of Immunology. https://doi.org/10.1002/eji.70003

Vancouver

Nguyen HO, Pinson PR, Andreola ML, Papagno L, Appay V. Human Type‐I Interferon Omega Holds Potent Antiviral Properties and Promotes Cytolytic CD8 + T Cell Responses. European Journal of Immunology. 2025. doi:10.1002/eji.70003

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Hoang Oanh and Pinson, Patricia Recordon and Andreola, Marie-Line and Papagno, Laura and Appay, Victor},
  title = {Human Type‐I Interferon Omega Holds Potent Antiviral Properties and Promotes Cytolytic CD8 + T Cell Responses},
  journal = {European Journal of Immunology},
  year = {2025},
  doi = {10.1002/eji.70003}
}
Kostenlos starten →